Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity aimed at supporting small businesses in developing technologies to address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. This initiative, identified as the R43/R44 Small Business Innovation Research (SBIR) Grant, encourages innovative solutions that tackle root social issues such as housing stability and food insecurity, with the goal of enhancing access to treatment and improving public health outcomes. Eligible U.S.-based small business concerns can apply for funding, with project budgets reaching up to $306,872 for Phase I and $2,045,816 for Phase II, and a total funding commitment of $2 million for approximately six awards. The application period opens on February 13, 2024, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the funding announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-048.html.
Eligible Applicants
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See full Notice of Funding Opportunity for additional information on eligibility.